<?xml version="1.0" encoding="iso-8859-1" ?>
<newsitem itemid="553099" id="root" date="1997-05-01" xml:lang="en">
<title>USA: LecTec Corp Q3 March 31 loss after charge.</title>
<headline>LecTec Corp Q3 March 31 loss after charge.</headline>
<dateline>MINNETONKA, Minn. 1997-05-01</dateline>
<text>
<p>Third Quarter	     Nine Months</p>
<p>				 March 31,		 March 31,</p>
<p>			    1997	1996	  1997	  1996</p>
<p> Net sales	$3,034,079 $3,812,332  $9,035,680 $10,529,893</p>
<p>Cost of goods sold</p>
<p>		     1,996,535  2,339,427   5,833,520   6,420,131</p>
<p>   Gross profit  1,037,544  1,472,905   3,202,160   4,109,762</p>
<p>Operating expenses</p>
<p>Selling, general and</p>
<p>   administrative  658,690    803,230   2,094,063   3,212,770</p>
<p>Research and development</p>
<p>			 316,524    531,675   1,228,452   1,546,226</p>
<p>Restructuring charge</p>
<p>		     1,500,000	   --   1,500,000	    --</p>
<p>		     2,475,214  1,334,905   4,822,515   4,758,996</p>
<p>Earnings (loss) from</p>
<p>operations</p>
<p>		   (1,437,670)    138,000  (1,620,355)  (649,234)</p>
<p>Other income (expense),</p>
<p>  net		   12,990	6,480	54,294	35,738</p>
<p>Earnings (loss) before</p>
<p>income taxes and</p>
<p>equity in losses of</p>
<p>unconsolidated</p>
<p>subsidiary</p>
<p>		   (1,424,680)    144,480  (1,566,061)  (613,496)</p>
<p> Income tax expense  1,693	1,981	 4,009	 3,158</p>
<p>Earnings (loss) before</p>
<p>equity in losses of</p>
<p>unconsoidated</p>
<p>subsidiary</p>
<p>		   (1,426,373)    142,499  (1,570,070)  (616,654)</p>
<p>Equity in losses of</p>
<p>unconsolidated</p>
<p>  subsidiary	  42,824	   --     126,067	    --</p>
<p>Net earnings (loss)</p>
<p>		   (1,469,197)    142,499 (1,696,137)   (616,654)</p>
<p>Net earnings (loss) per</p>
<p>  common share     ( 0.38)	 0.04     ( 0.44)     ( 0.16)</p>
<p>Weighted average number</p>
<p>of common shares out-</p>
<p>standing during the</p>
<p>  period	   3,835,989  3,872,428   3,835,978   3,870,896</p>
<p>NOTE: 1997 Q3 and nine months loss includes restructuring charge  of $1.5 million or $0.39 a share related to plan to eliminate Pharmadyne Corp subsidiary.</p>
<p>		((Chicago newsdesk 312 408 8787))</p>
</text>
<copyright>(c) Reuters Limited 1997</copyright>
<metadata>
<codes class="bip:countries:1.0">
  <code code="USA">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-05-01"/>
  </code>
</codes>
<codes class="bip:industries:1.0">
  <code code="I37200">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-05-01"/>
  </code>
</codes>
<codes class="bip:topics:1.0">
  <code code="C15">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-05-01"/>
  </code>
  <code code="C151">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-05-01"/>
  </code>
  <code code="CCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-05-01"/>
  </code>
</codes>
<dc element="dc.date.created" value="1997-05-01"/>
<dc element="dc.publisher" value="Reuters Holdings Plc"/>
<dc element="dc.date.published" value="1997-05-01"/>
<dc element="dc.source" value="Reuters"/>
<dc element="dc.creator.location" value="MINNETONKA, Minn."/>
<dc element="dc.creator.location.country.name" value="USA"/>
<dc element="dc.source" value="Reuters"/>
</metadata>
</newsitem>
